Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PBH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 3
317 filers reported a long position in PBH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $370.2M | 7.8M | +6% |
| ARIEL INVESTMENTS, LLC | $230.1M | 4.9M | +13.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133.6M | 2.8M | +0.8% |
| DIMENSIONAL FUND ADVISORS LP | $125.8M | 2.7M | -0.4% |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110.2M | 2.3M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $101M | 2.1M | +2.1% |
| STATE STREET CORP | $100M | 2.1M | +7.4% |
| BRANDES INVESTMENT PARTNERS, LP | $97M | 2.1M | +140.1% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88.5M | 1.9M | -15% |
| GEODE CAPITAL MANAGEMENT, LLC | $74.3M | 1.6M | +7.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.